The Office of Oncologic Diseases (OOD) is responsible for making safe and effective drugs for cancer available to the U.S. public.  OOD has the following components:

• Immediate Office
• Division of Oncology 1 (DO1)
• Division of Oncology 2 (DO2)
• Division of Oncology 3 (DO3)
• Division of Hematologic Malignancies 1 (DHM1)
• Division of Hematologic Malignancies 2 (DHM2)
• Division of Hematology Oncology Toxicology
• CDER Key Officials List (PDF - 125KB)
• CDER Offices and Divisions

Resources For You

• Information for Sponsors: Submissions to the Office of Oncologic Diseases (OOD)

• Office of Oncologic Diseases (OOD)